Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 05-2015 | 03-2015 | 02-2015 | 12-2014 | 11-2014 | |
| Sales | 4 | 144 | 144 | 24 | 24 |
| Cost of Goods | 2 | N/A | 155 | 20 | 20 |
| Gross Profit | 2 | 144 | 2 | 5 | 5 |
| Operating Expenses | 2,100 | 0 | 2,510 | 2,670 | 2,650 |
| Operating Income | -2,098 | 144 | -2,521 | -2,646 | -2,646 |
| Interest Expense | 60 | 0 | -2 | 1 | 0 |
| Other Income | 1,378 | 0 | 550 | 5,337 | 5,336 |
| Pre-tax Income | -780 | 144 | -1,970 | 2,690 | 2,690 |
| Net Income Continuous | -780 | -1,869 | -1,869 | 2,534 | 2,534 |
| Net Income | $-780 | $-1,869 | $-1,869 | $2,534 | $2,534 |
| EPS Basic Total Ops | -0.10 | -9.60 | -0.20 | 14.40 | 0.30 |
| EPS Basic Continuous Ops | -0.07 | -7.76 | -0.16 | 11.45 | 0.24 |
| EPS Diluted Total Ops | -0.10 | -9.60 | -0.20 | 14.40 | 0.30 |
| EPS Diluted Continuous Ops | -0.07 | -7.76 | -0.16 | 11.35 | 0.24 |
| EBITDA(a) | $-1,628 | $654 | $-2,011 | $-2,156 | $-2,156 |